NEW YORK, July 11 – Ventana Medical Systems and BD Biosciences Clontech Laboratories have agreed to non-exclusively co-market their microarray products, the companies said Wednesday.
Together, the two companies will co-promote BD Biosciences’ DNA microarrays, and Ventana’s microarray analysis platform. Financial details of the deal were not disclosed.
BD Biosciences Clontech, based in Palo Alto, Calif, manufactures pre-spotted glass microarrays containing up to 3800 human, mouse, and rat DNA oligonucleotides. Ventana’s microarray analysis system automates slide staining for hybridizing DNA microarrays in gene expression and other experiments.
Ventana, based in Tucson, Ariz., has partnered with Genicon Sciences to develop its microarray analysis system.